These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 28132002

  • 1. Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.
    Moafi M, Rezvan H, Sherkat R, Taleban R, Asilian A, Zarkesh Esfahani SH, Nilforoushzadeh MA, Jaffary F, Feizi A.
    BMJ Open; 2017 Jan 27; 7(1):e013006. PubMed ID: 28132002
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel IL-12Rβ1 deficiency-mediates recurrent cutaneous leishmaniasis.
    Khattak FA, Akbar NU, Riaz M, Hussain M, Rehman K, Khan SN, Khan TA.
    Int J Infect Dis; 2021 Nov 27; 112():338-345. PubMed ID: 34438084
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275.
    Reddy M, Davis C, Wong J, Marsters P, Pendley C, Prabhakar U.
    Cell Immunol; 2007 May 27; 247(1):1-11. PubMed ID: 17761156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In situ cytokines (IL-4, IL-10, IL-12, IFN-γ) and chemokines (MCP-1, MIP-1α) gene expression in human Leishmania (Leishmania) Mexicana infection.
    Valencia-Pacheco G, Loría-Cervera EN, Sosa-Bibiano EI, Canché-Pool EB, Vargas-Gonzalez A, Melby PC, Andrade-Narvaez FJ.
    Cytokine; 2014 Sep 27; 69(1):56-61. PubMed ID: 25022962
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
    Oliveira PR, Dessein H, Romano A, Cabantous S, de Brito ME, Santoro F, Pitta MG, Pereira V, Pontes-de-Carvalho LC, Rodrigues V, Rafati S, Argiro L, Dessein AJ.
    J Immunol; 2015 Mar 15; 194(6):2664-72. PubMed ID: 25672756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Wound healing in cutaneous leishmaniasis: A double edged sword of IL-10 and TGF-β.
    Abdoli A, Maspi N, Ghaffarifar F.
    Comp Immunol Microbiol Infect Dis; 2017 Apr 15; 51():15-26. PubMed ID: 28504090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A, de Cássia Bittar R, Dos Santos Nogueira R, Amato VS, da Silva Mattos M, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM.
    Clin Exp Immunol; 2007 Sep 15; 149(3):440-4. PubMed ID: 17614975
    [Abstract] [Full Text] [Related]

  • 16. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V.
    Hum Immunol; 2009 Jun 15; 70(6):383-90. PubMed ID: 19480861
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis.
    Melby PC, Andrade-Narvaez F, Darnell BJ, Valencia-Pacheco G.
    FEMS Immunol Med Microbiol; 1996 Sep 15; 15(2-3):101-7. PubMed ID: 8880134
    [Abstract] [Full Text] [Related]

  • 19. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells.
    Geiger B, Wenzel J, Hantschke M, Haase I, Ständer S, von Stebut E.
    Br J Dermatol; 2010 Apr 15; 162(4):870-4. PubMed ID: 19906074
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.